Johannis A. Van Rossum
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients.
Journal: Multiple sclerosis and related disorders
Published: October 30, 2020
Infusion-related events during natalizumab: No need for post-infusion monitoring.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 26, 2019
Abnormalities and erythroblasts in peripheral blood of multiple sclerosis patients treated with natalizumab.
Journal: Multiple sclerosis and related disorders
Published: May 27, 2019
Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient.
Journal: Multiple sclerosis and related disorders
Published: March 02, 2019
Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation.
Journal: Journal of neurology
Published: March 01, 2019
gMS-Classifier1 does not predict disability progression in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 01, 2018
High cumulative JC virus seroconversion rate during long-term use of natalizumab.
Journal: European journal of neurology
Published: September 21, 2015
Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.
Journal: AJNR. American journal of neuroradiology
Published: September 11, 2014
The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 13, 2014
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 05, 2014
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 29, 2014
Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 06, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026